Renal Denervation

One highlight of Tuesday at CRT is Renal Denervation and Hypertension Therapies. During this morning session, attendees will receive updates on renal denervation treatment for resistant hypertension, new findings that may impact the outcome of renal denervation, and new data and clinical trial designs.

These talks bring experts from the ongoing SPYRAL HTN studies to discuss the latest trial results, cost analyses, progress toward optimization of renal denervation and the state of hypertension treatment in the U.S.